Vertex Pharmaceuticals
VRTX
#206
Rank
HK$878.23 B
Marketcap
HK$3,460
Share price
3.13%
Change (1 day)
-1.05%
Change (1 year)

EPS for Vertex Pharmaceuticals (VRTX)

EPS in 2026 (TTM): HK$132.87

According to Vertex Pharmaceuticals's latest financial reports the company's current EPS (TTM) is HK$133.24. In 2025 the company made an earnings per share (EPS) of HK$121.18 an increase over its 2024 EPS that were of -HK$16.14.

EPS history for Vertex Pharmaceuticals from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)HK$132.879.64%
2025HK$121.18-850.97%
2024-HK$16.14-114.67%
2023HK$109.988.17%
2022HK$101.6842.64%
2021HK$71.28-12.67%
2020HK$81.62128.01%
2019HK$35.80-44.54%
2018HK$64.55670.09%
2017HK$8.38-327.66%
2016-HK$3.68-79.65%
2015-HK$18.09-26.43%
2014-HK$24.6053.92%
2013-HK$15.98316.33%
2012-HK$3.84

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$68.43-48.64%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
HK$16.11-87.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
HK$53.66-59.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$27.87-79.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$27.89-79.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Enanta Pharmaceuticals
ENTA
-HK$30.00-122.52%๐Ÿ‡บ๐Ÿ‡ธ USA